Phaidra, Inc. is a Seattle-based company established in 2019 that specializes in designing and developing artificial intelligence solutions for industrial sectors in the United States. The company focuses on providing AI and machine learning technologies aimed at enhancing performance in large-scale facilities. Phaidra's offerings include a virtual plant operator service that utilizes closed-loop AI control to empower operations teams in mission-critical environments. By analyzing extensive sensor data, Phaidra creates intelligent agents that automatically optimize and manage complex industrial processes. This innovative approach helps clients improve energy efficiency, increase safety and stability, and maximize operational yield, contributing to greater sustainability in their operations.
Lark is a developer of a virtual platform focused on chronic disease prevention and management. Founded in 2011 by Julia Hu and Jeff Zira, the company is headquartered in Mountain View, California. Lark's platform leverages advanced artificial intelligence alongside human coaching and connected devices to offer real-time, personalized support and counseling. This approach aims to help users make healthier choices and effectively manage their chronic conditions. The company's programs, including those recognized by the CDC for diabetes prevention, wellness, diabetes care, and hypertension, serve approximately 1.5 million users. These initiatives have shown clinically validated improvements in health outcomes, as documented in multiple peer-reviewed journals and analyst reports.
nFlux AI
Pre Seed Round in 2020
nFlux AI is a developer of an artificial general intelligence platform focused on enhancing human capabilities through advanced technology. The company specializes in computer vision operations, providing intelligent video analytics that automate the extraction of contextual insights from unstructured data within video footage. This innovative approach allows clients to leverage proprietary machine comprehension services, enabling a deeper understanding of their data. nFlux's first significant collaboration was with NASA, where the company was tasked with creating a cognitive architecture to support deep space missions, allowing intelligent systems to assist astronauts autonomously when communication with Earth is not feasible. The company's vision is to advance intelligence in ways that positively impact humanity, supported by investments from prominent organizations and venture capital firms.
ECFX
Debt Financing in 2019
ECFX develops software for the legal industry. Its flagship product, ECFX Notice, automates the management of electronic court notices, streamlining workflows by processing documents, applying firm-defined policies, and distributing them to relevant team members via email or secure platforms.
Neyborly
Seed Round in 2019
Neyborly is a commercial real estate company focused on transforming under-utilized urban spaces into vibrant community hubs for events, meetings, and pop-up activities. By revitalizing vacant properties, Neyborly provides customizable and affordable rental spaces that cater to a variety of needs, such as birthday parties, corporate meetings, and art shows. The company leverages design, data, and exceptional customer service to create unique environments that foster connection and creativity. Committed to democratizing access to real estate, Neyborly aims to reshape how individuals and organizations utilize spaces in their neighborhoods, ultimately bringing people together to celebrate and inspire within their communities.
Activeconnect
Venture Round in 2018
Activeconnect works on all types of devices and operating systems for every transaction including iOS, Android, Windows, and Mac OS. We provide a well-documented API and everything needed to build applications that have frictionless step-up authentication without needing passwords. Activeconnect’s technology powers authentication for any platform, web application, mobile application, software, and just about everything that needs user authentication and secure transactions.
We help our Clients Avoid Account Takeover (ATO), reduce fraud and enable frictionless security steps to make any transaction secure, easy, cost-effective, and instantly scalable.
Athira Pharma
Series B in 2017
Athira Pharma is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for brain disorders. Its lead product candidate, ATH-1017, aims to treat neurodegenerative diseases like Alzheimer's and Parkinson's by restoring neuronal health.